No Data
No Data
Hong Kong stock pharmaceutical stocks are in high demand, 3SBIO skyrocketed over 11%, and Jiangsu Hengrui Pharmaceuticals is about to go public on the Hong Kong stock market.
Jiangsu Hengrui Pharmaceuticals plans to globally issue approximately 0.225 billion shares, with a net fundraising amount of 94.578 million Hong Kong dollars. The company's issuance price is between 41.45 and 44.05 Hong Kong dollars, with 200 shares per lot and a subscription amount of 8,898.95 Hong Kong dollars per lot.
Deutsche Bank Adjusts Olin Price Target to $24 From $32, Maintains Hold Rating
Express News | Olin : Deutsche Bank Cuts Target Price to $24 From $32
Olin To Go Ex-Dividend On May 15th, 2025 With 0.2 USD Dividend Per Share
May 13th (Eastern Time) - $Olin(OLN.US)$ is trading ex-dividend on May 15th, 2025.Shareholders of record on May 15th, 2025 will receive 0.2 USD dividend per share on June 13th, 2025. The ex-dividend
Morgan Stanley Maintains Olin(OLN.US) With Sell Rating, Cuts Target Price to $20
Shares of Companies Within the Broader Materials Sector Are Trading Higher Amid Overall Market Strength After the US and China Agreed to a Temporary Reduction in Most Tariffs on Each Other's Goods. A Decrease of Trade Tensions Could Reduce Demand...